drugset / Trial / NCT04539626
Estrogen Therapy in Non-severe COVID-19 Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective of this study is to evaluate the effect of additional estradiol estrogen therapy on clinical response and mortality in non-severe COVID-19 patients
Timeline
- Start
- 2020-10-01
- Primary completion
- 2023-04-03
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ethinyl estradiol | Small molecule | 0.6 mg | Other |
| Subject | ethinyl estradiol | Small molecule | 6 mg | Other |